CEO.CA SEDI filings for

SEDI Insider filing browser

Date	Issuer	Insider	Transaction	Amount	New Balance ⓘ The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2018-07-06 Tx date 2018-06-29	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,234 +1,344 vol $23.24 each	70,232
Filed 2018-07-06 Tx date 2018-06-29	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,234 +1,344 vol $23.24 each	24,801
Filed 2018-07-06 Tx date 2018-06-29	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$27,492 +1,183 vol $23.24 each	38,140
Filed 2018-07-06 Tx date 2018-06-29	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$37,486 +1,613 vol $23.24 each	73,707
Filed 2018-05-28 Tx date 2018-05-23	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	-21,612 vol	12,803
Filed 2018-05-18 Tx date 2018-05-15	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$327,450 +15,000 vol $21.83 each	109,926
Filed 2018-05-11 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-186,684 vol	300,335
Filed 2018-05-11 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$3,418,184 +186,684 vol $18.31 each	418,684
Filed 2018-05-11 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	$-63,642.54 -3,522 vol $18.07 each	94,926
Filed 2018-05-11 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$459,086 +25,406 vol $18.07 each	98,448
Filed 2018-05-11 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-1,683,458.02 -91,942 vol $18.31 each	326,742
Filed 2018-05-11 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-25,406 vol	23,457
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	68,888
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	57,109
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	72,094
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Power, Robert Noel 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	65,508
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Power, Robert Noel 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	36,957
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	53,745
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	56,013
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	48,863
Filed 2018-05-10 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-09 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+13,881 vol	13,881
Filed 2018-05-09 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-07 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-07 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	14,285
Filed 2018-05-07 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	49,267
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	37,361
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	54,149
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	56,417
Filed 2018-05-04 Tx date 2018-05-01	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$390,528 +21,612 vol $18.07 each	34,415
Filed 2018-05-04 Tx date 2018-05-01	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-25,406 vol	0
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	69,292
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	57,513
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	72,498
Filed 2018-05-04 Tx date 2018-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Power, Robert Noel 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+14,285 vol	65,912
Filed 2018-04-06 Tx date 2018-03-30	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,235 +1,962 vol $15.92 each	34,982
Filed 2018-04-06 Tx date 2018-03-30	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$27,493 +1,727 vol $15.92 each	23,076
Filed 2018-04-06 Tx date 2018-03-30	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,235 +1,962 vol $15.92 each	55,007
Filed 2018-04-06 Tx date 2018-03-30	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$37,491 +2,355 vol $15.92 each	58,213
Filed 2018-03-29 Tx date 2018-03-26	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)	Bonds Corporate Bond 5.375% 03/15/2020 38 - Redemption, retraction, cancellation, repurchase	$ -$75,000,000 vol $1,013 each	$0
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+22,162 vol	72,849
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+113,652 vol	487,019
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+511,434 vol	511,434
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 97 - Other	-933,416 vol	0
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$5,179,048 +338,058 vol $15.32 each	1,020,710
Filed 2018-03-14 Tx date 2018-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$481,500 +30,000 vol $16.05 each	232,000
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+59,667 vol	159,667
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+79,556 vol	79,556
Filed 2018-03-14 Tx date 2016-08-22	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,719,024 +177,482 vol $15.32 each	1,177,482
Filed 2018-03-14 Tx date 2018-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$241,469 +15,000 vol $16.10 each	71,825
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+10,654 vol	55,048
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+7,104 vol	15,638
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$485,598 +31,697 vol $15.32 each	63,127
Filed 2018-03-14 Tx date 2018-03-08	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$153,400 +10,000 vol $15.34 each	73,042
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+14,776 vol	27,347
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$1,009,940 +65,923 vol $15.32 each	96,097
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+20,457 vol	66,071
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+13,638 vol	48,136
Filed 2018-03-14 Tx date 2018-03-07	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$932,267 +60,853 vol $15.32 each	160,667
Filed 2018-03-09 Tx date 2018-03-06	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson International Ltd (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	$-28,349,844.60 -1,840,899 vol $15.40 each	1,211,761
Filed 2018-03-09 Tx date 2018-03-06	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Enhanced Ltd (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	$-63,558,264 -4,127,160 vol $15.40 each	2,961,296
Filed 2018-03-09 Tx date 2018-03-06	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners LP (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	$108,826,086 +7,066,629 vol $15.40 each	7,215,361
Filed 2018-03-09 Tx date 2018-03-06	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners Enhanced LP (Control or Direction)	Common Shares 11 - Acquisition or disposition carried out privately	$-16,917,978 -1,098,570 vol $15.40 each	405,317
Filed 2018-01-30 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-30,146.40 -1,264 vol $23.85 each	37,237
Filed 2018-01-30 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-37,134.45 -1,557 vol $23.85 each
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-8,191 vol	45,614
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$101,744 +4,266 vol $23.85 each	16,037
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$195,355 +8,191 vol $23.85 each	16,759
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-87,028.65 -3,649 vol $23.85 each	13,110
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-4,266 vol	44,394
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-43,550.10 -1,826 vol $23.85 each	14,211
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-4,095 vol	50,687
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-37,134.45 -1,557 vol $23.85 each	36,944
Filed 2018-01-10 Tx date 2018-01-08	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$97,665 +4,095 vol $23.85 each	38,501
Filed 2018-01-05 Tx date 2018-01-03	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$899,316 +43,278 vol $20.78 each	43,278
Filed 2018-01-05 Tx date 2018-01-03	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-43,278 vol	86,560
Filed 2018-01-05 Tx date 2018-01-03	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-306,089.40 -14,730 vol $20.78 each	28,548
Filed 2018-01-05 Tx date 2017-01-02	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2018-01-03 Tx date 2017-06-30	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$4,653 +269 vol $17.30 each	18,166
Filed 2018-01-03 Tx date 2017-12-29	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,503 vol	53,045
Filed 2018-01-03 Tx date 2017-12-29	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,804 vol	55,858
Filed 2018-01-03 Tx date 2017-12-29	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$27,491 +1,323 vol $20.78 each	21,349
Filed 2018-01-03 Tx date 2017-09-29	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$26,653 +1,860 vol $14.33 each	20,026
Filed 2018-01-03 Tx date 2017-12-29	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,503 vol	33,020
Filed 2017-11-21 Tx date 2017-11-16	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson International Ltd (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$3,540,963 +245,960 vol $14.40 each	3,052,660
Filed 2017-11-21 Tx date 2017-11-16	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Separately Managed Account (Control or Direction)	Equity Swap - Long Position 70 - Acquisition or disposition (writing) of third party derivative	$-3,726,030.75 -259,500 vol $14.36 each	0
Filed 2017-11-21 Tx date 2017-11-16	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-159,757.7361 -11,103 vol $14.39 each	148,732
Filed 2017-11-21 Tx date 2017-11-16	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners Enhanced LP (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-4,793,063.0231 -333,113 vol $14.39 each	1,503,887
Filed 2017-11-21 Tx date 2017-11-16	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Enhanced Ltd (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$1,414,542 +98,256 vol $14.40 each	7,088,456
Filed 2017-11-21 Tx date 2017-11-17	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$143,300 +10,000 vol $14.33 each	63,042
Filed 2017-10-04 Tx date 2017-09-29	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,239 +2,180 vol $14.33 each	51,542
Filed 2017-10-04 Tx date 2017-09-29	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$37,487 +2,616 vol $14.33 each	54,054
Filed 2017-10-04 Tx date 2017-09-29	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,239 +2,180 vol $14.33 each	31,517
Filed 2017-08-25 Tx date 2017-08-23	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$707,000 +50,000 vol $14.14 each	74,000
Filed 2017-08-25 Tx date 2017-08-23	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	$-707,000 -50,000 vol $14.14 each	100,000
Filed 2017-08-25 Tx date 2017-08-23	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-242,854.50 -17,175 vol $14.14 each	56,825
Filed 2017-08-24 Tx date 2017-08-18	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-80,471.05 -5,687 vol $14.15 each	34,406
Filed 2017-08-24 Tx date 2017-08-21	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$70,315 +4,900 vol $14.35 each	53,042
Filed 2017-08-24 Tx date 2017-08-21	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$72,981 +5,100 vol $14.31 each	48,142
Filed 2017-08-24 Tx date 2017-08-18	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	$-300,645.05 -21,247 vol $14.15 each	54,782
Filed 2017-08-24 Tx date 2017-08-18	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$300,645 +21,247 vol $14.15 each	40,093
Filed 2017-08-14 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$224,617 +14,614 vol $15.37 each	14,614
Filed 2017-08-14 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-14,614 vol	53,805
Filed 2017-08-14 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-92,927.02 -6,046 vol $15.37 each	8,568
Filed 2017-08-14 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-11 Tx date 2017-08-11	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)	Bonds Corporate Bond 5.875% 05/15/2023 10 - Acquisition or disposition in the public market	$ -$8,000,000 vol $84.50 each
Filed 2017-08-11 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)	Bonds Corporate Bond 6.125% 04/15/2025 10 - Acquisition or disposition in the public market	$ -$13,000,000 vol $84.92 each	$90,000,000
Filed 2017-08-11 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)	Bonds Corporate Bond 6.125% 04/15/2025 10 - Acquisition or disposition in the public market	$ -$37,000,000 vol $84.00 each	$103,000,000
Filed 2017-08-11 Tx date 2017-08-11	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)	Bonds Corporate Bond 5.875% 05/15/2023 10 - Acquisition or disposition in the public market	$ -$8,000,000 vol $84.50 each	$0
Filed 2017-08-11 Tx date 2017-08-10	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Indirect Ownership)	Bonds Corporate Bond 5.875% 05/15/2023 10 - Acquisition or disposition in the public market	$ -$2,000,000 vol $84.63 each	$8,000,000
Filed 2017-08-09 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners LP (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-8,482,939.5675 -578,665 vol $14.66 each	159,835
Filed 2017-08-09 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Separately Managed Account (Indirect Ownership)	Equity Swap - Long Position 70 - Acquisition or disposition (writing) of third party derivative	$-8,806,573.80 -603,000 vol $14.60 each	259,500
Filed 2017-08-09 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Separately Managed Account (Control or Direction)	Equity Swap - Long Position 00 - Opening Balance-Initial SEDI Report		862,500
Filed 2017-08-09 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Separately Managed Account (Control or Direction)	Equity Swap - Long Position 00 - Opening Balance-Initial SEDI Report
Filed 2017-08-09 Tx date 2017-08-09	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners Premium LP (Indirect Ownership)	Common Shares 10 - Acquisition or disposition in the public market	$-362,089.65 -24,700 vol $14.66 each	0
Filed 2017-07-06 Tx date 2017-06-30	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,243 +1,806 vol $17.30 each	49,362
Filed 2017-07-06 Tx date 2017-06-30	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,261 +1,807 vol $17.30 each	29,337
Filed 2017-07-06 Tx date 2017-06-30	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$37,489 +2,167 vol $17.30 each	51,438
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 1 (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		125
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report		17,897
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Separately Managed Account (Control or Direction)	Equity Swap - Long Position 00 - Opening Balance-Initial SEDI Report		1
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 3 (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 2 (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 1 (Indirect Ownership)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 4 (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		30
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 3 (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		35
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: UTMA Account 2 (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		30
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Recovery Master Fund (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		2,500,000
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners Premium LP (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		24,700
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners LP (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		738,500
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Partners Enhanced LP (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,837,000
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson International Ltd (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		2,806,700
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Enhanced Ltd (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		6,990,200
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Advantage Plus Master Ltd (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		4,836,200
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Advantage Master Ltd (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,709,100
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Control or Direction)	Bonds Corporate Bond 6.125% 04/15/2025 00 - Opening Balance-Initial SEDI Report		$140,000,000
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Control or Direction)	Bonds Corporate Bond 5.875% 05/15/2023 00 - Opening Balance-Initial SEDI Report		$10,000,000
Filed 2017-06-26 Tx date 2017-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Paulson, John 4 - Director of Issuer Holder: Paulson Credit Opportunities Master Ltd (Control or Direction)	Bonds Corporate Bond 5.375% 03/15/2020 00 - Opening Balance-Initial SEDI Report		$75,000,000
Filed 2017-06-12 Tx date 2017-06-07	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-17,930 vol	48,660
Filed 2017-06-12 Tx date 2017-06-07	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-77,049.09 -6,159 vol $12.51 each	11,771
Filed 2017-06-12 Tx date 2017-06-07	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$224,304 +17,930 vol $12.51 each	17,930
Filed 2017-06-12 Tx date 2016-06-15	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-05-15 Tx date 2017-05-11	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$278,000 +20,000 vol $13.90 each	43,042
Filed 2017-05-15 Tx date 2017-05-10	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-12,230 vol	76,029
Filed 2017-05-15 Tx date 2017-05-10	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-31,790.54 -3,274 vol $9.71 each	18,846
Filed 2017-05-15 Tx date 2017-05-10	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$118,753 +12,230 vol $9.71 each	22,120
Filed 2017-05-09 Tx date 2017-05-08	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-11,190 vol	27,530
Filed 2017-05-09 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	38,720
Filed 2017-05-09 Tx date 2017-05-08	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	$-20,749.68 -2,148 vol $9.66 each	23,042
Filed 2017-05-09 Tx date 2017-05-08	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$108,095 +11,190 vol $9.66 each	25,190
Filed 2017-05-08 Tx date 2017-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$161,573 +16,726 vol $9.66 each	17,796
Filed 2017-05-08 Tx date 2017-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	$-47,372.64 -4,904 vol $9.66 each	12,892
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	47,556
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	43,228
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,046 vol
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	49,271
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Power, Robert Noel 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	51,627
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	39,864
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	42,132
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	25,406
Filed 2017-05-08 Tx date 2017-05-05	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+25,406 vol	25,406
Filed 2017-05-08 Tx date 2017-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-16,726 vol	0
Filed 2017-05-08 Tx date 2017-05-03	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	+16,726 vol
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	-12,803 vol
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-16,726 vol	0
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-16,726 vol
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-16,726 vol
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$123,676 +12,803 vol $9.66 each	12,803
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	-12,803 vol
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$123,676 +12,803 vol $9.66 each
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$123,676 +12,803 vol $9.66 each
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 97 - Other	+12,803 vol
Filed 2017-05-05 Tx date 2017-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 97 - Other	+12,803 vol
Filed 2017-04-10 Tx date 2017-03-31	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$34,490 +3,127 vol $11.03 each	23,865
Filed 2017-04-10 Tx date 2017-03-31	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$23,383 +2,120 vol $11.03 each	85,263
Filed 2017-04-10 Tx date 2017-03-31	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$23,427 +2,124 vol $11.03 each	13,314
Filed 2017-04-10 Tx date 2017-03-31	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$27,133 +2,460 vol $11.03 each	22,150
Filed 2017-03-30 Tx date 2017-03-28	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+63,742 vol	88,259
Filed 2017-03-18 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$257,280 +24,000 vol $10.72 each	24,000
Filed 2017-03-18 Tx date 2016-08-22	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-18 Tx date 2017-03-15	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$108,000 +10,000 vol $10.80 each	14,000
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$128,475,502 +2,696,233 vol $47.65 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$3,232,766 +67,844 vol $47.65 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$202,099,708 +4,241,337 vol $47.65 each	0
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$-6,343.80 -21,146 vol $0.30 each	0
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$-8,088.60 -26,962 vol $0.30 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-96,581,430 -8,780,130 vol $11.00 each	0
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$-203.40 -678 vol $0.30 each	0
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$-12,724.20 -42,414 vol $0.30 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-28,662,183 -2,605,653 vol $11.00 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-343,519 -31,229 vol $11.00 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-73,671,620 -6,697,420 vol $11.00 each	0
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	-1,114 vol	0
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 97 - Other	+2,963 vol	16,937,431
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	+2,500,000 vol	16,934,468
Filed 2017-03-17 Tx date 2017-03-14	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	+500,000 vol	14,434,468
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$100,760,022 +2,114,586 vol $47.65 each	0
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$85,957,920 +2,114,586 vol $40.65 each
Filed 2017-03-17 Tx date 2017-03-13	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$85,957,920 +2,114,586 vol $40.65 each
Filed 2017-03-06 Tx date 2017-01-02	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-06 Tx date 2017-03-01	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$2,169,352 +150,859 vol $14.38 each	150,859
Filed 2017-03-06 Tx date 2017-01-06	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+12,799 vol	66,590
Filed 2017-03-06 Tx date 2016-06-15	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report		53,791
Filed 2017-03-06 Tx date 2017-01-06	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+8,534 vol	8,534
Filed 2017-03-06 Tx date 2016-06-15	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-06 Tx date 2017-03-01	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$451,963 +31,430 vol $14.38 each	31,430
Filed 2017-03-06 Tx date 2017-03-01	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$433,902 +30,174 vol $14.38 each	30,174
Filed 2017-03-06 Tx date 2016-08-17	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-03-06 Tx date 2017-03-01	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	$867,761 +60,345 vol $14.38 each	99,814
Filed 2017-03-06 Tx date 2016-06-15	$VRX Valeant Pharmaceuticals International, Inc.	Eldessouky, Osama 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-11 Tx date 2017-01-06	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+4,096 vol	12,571
Filed 2017-01-11 Tx date 2017-01-06	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+24,575 vol	68,419
Filed 2017-01-11 Tx date 2017-01-06	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+8,192 vol	34,498
Filed 2017-01-11 Tx date 2017-01-06	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+12,287 vol	24,517
Filed 2017-01-06 Tx date 2017-01-02	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+129,838 vol	129,838
Filed 2017-01-06 Tx date 2017-01-02	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06 Tx date 2017-01-02	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+41,002 vol	41,002
Filed 2017-01-06 Tx date 2017-01-02	$VRX Valeant Pharmaceuticals International, Inc.	Humphries, William Douglas 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06 Tx date 2017-01-03	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$170,535 +11,190 vol $15.24 each	11,190
Filed 2017-01-06 Tx date 2017-01-01	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		4,000
Filed 2017-01-06 Tx date 2017-01-01	$VRX Valeant Pharmaceuticals International, Inc.	DE SCHUTTER, Richard Urbain 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2017-01-06 Tx date 2016-12-30	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$24,988 +1,721 vol $14.52 each	19,690
Filed 2017-01-06 Tx date 2016-12-30	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$33,744 +2,324 vol $14.52 each	20,738
Filed 2017-01-06 Tx date 2016-12-30	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$21,242 +1,463 vol $14.52 each	83,143
Filed 2016-12-22 Tx date 2016-08-02	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$58,850 +2,500 vol $23.54 each	10,000
Filed 2016-12-22 Tx date 2016-08-02	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-2,500 vol	42,935
Filed 2016-12-22 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-108,216 -6,012 vol $18.00 each	15,799
Filed 2016-12-22 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-117,090 -6,505 vol $18.00 each
Filed 2016-12-22 Tx date 2016-08-02	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-19,632.36 -834 vol $23.54 each	9,166
Filed 2016-12-19 Tx date 2016-12-14	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$73,650 +5,000 vol $14.73 each	9,000
Filed 2016-12-16 Tx date 2016-12-12	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-49,883,793.30 -3,359,178 vol $14.85 each	2,605,653
Filed 2016-12-16 Tx date 2016-12-12	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	$25,315 +2,531,559 vol $0.01 each	0
Filed 2016-12-16 Tx date 2016-12-12	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	$28,378 +2,837,875 vol $0.01 each	0
Filed 2016-12-16 Tx date 2016-12-12	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	$631.22 +63,122 vol $0.01 each	0
Filed 2016-12-16 Tx date 2016-12-12	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	$36,874 +3,687,444 vol $0.01 each	0
Filed 2016-12-16 Tx date 2016-12-12	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	Common Shares 10 - Acquisition or disposition in the public market	$-1,745,053.20 -117,512 vol $14.85 each	31,229
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-38,441 vol	104,700
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-12,645 vol	32,790
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-117,090 -6,505 vol $18.00 each	13,640
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$227,610 +12,645 vol $18.00 each	20,145
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-28,325 vol	73,270
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-264,366 -14,687 vol $18.00 each	36,413
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$509,850 +28,325 vol $18.00 each	51,100
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-358,776 -19,932 vol $18.00 each	76,142
Filed 2016-12-12 Tx date 2016-12-05	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$691,938 +38,441 vol $18.00 each	96,074
Filed 2016-11-14 Tx date 2016-11-04	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$18,023 +817 vol $22.06 each
Filed 2016-11-14 Tx date 2016-11-04	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-18,023.02 -817 vol $22.06 each	22,775
Filed 2016-11-10 Tx date 2016-11-04	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$18,023 +817 vol $22.06 each	24,409
Filed 2016-11-10 Tx date 2016-11-04	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-1,575 vol	101,595
Filed 2016-11-10 Tx date 2016-11-04	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$34,744 +1,575 vol $22.06 each	23,592
Filed 2016-10-06 Tx date 2016-09-30	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,376 vol	18,414
Filed 2016-10-06 Tx date 2016-09-30	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,018 vol	17,969
Filed 2016-10-06 Tx date 2016-09-30	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+865 vol	81,680
Filed 2016-09-06 Tx date 2016-08-17	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report		9,890
Filed 2016-09-06 Tx date 2016-08-17	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report		8,475
Filed 2016-09-06 Tx date 2016-08-17	$VRX Valeant Pharmaceuticals International, Inc.	Appio, Thomas 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report		12,230
Filed 2016-09-02 Tx date 2016-08-22	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+1,000,000 vol	1,000,000
Filed 2016-09-02 Tx date 2016-08-22	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$4,311,000 +150,000 vol $28.74 each	150,000
Filed 2016-09-02 Tx date 2016-08-22	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-09-02 Tx date 2016-08-22	$VRX Valeant Pharmaceuticals International, Inc.	Herendeen, Paul 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-15 Tx date 2016-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-15 Tx date 2016-08-11	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$98,600 +4,000 vol $24.65 each	4,000
Filed 2016-08-15 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-15 Tx date 2016-08-10	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+39,469 vol	39,469
Filed 2016-08-12 Tx date 2016-08-03	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-31,496.52 -1,338 vol $23.54 each	22,017
Filed 2016-08-12 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+26,306 vol
Filed 2016-08-12 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	$600,039 +26,306 vol $22.81 each	26,306
Filed 2016-08-12 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+43,844 vol	43,844
Filed 2016-08-12 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	-26 vol
Filed 2016-08-12 Tx date 2016-07-20	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+2,580 vol
Filed 2016-08-12 Tx date 2016-08-03	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+2,580 vol	23,355
Filed 2016-08-12 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	-26 vol
Filed 2016-08-12 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	$-618.28 -26 vol $23.78 each	1,070
Filed 2016-08-12 Tx date 2016-07-27	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$339,618 +14,458 vol $23.49 each	14,458
Filed 2016-08-12 Tx date 2016-08-03	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$339,618 +14,458 vol $23.49 each
Filed 2016-08-12 Tx date 2016-08-03	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	-1,338 vol
Filed 2016-08-12 Tx date 2016-07-20	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-2,580 vol
Filed 2016-08-12 Tx date 2016-08-03	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-2,580 vol	103,170
Filed 2016-08-11 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-06-30	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$4,531 +225 vol $20.14 each	16,951
Filed 2016-08-11 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	16,726
Filed 2016-08-11 Tx date 2016-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Wechsler, Amy 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-06-30	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$6,283 +312 vol $20.14 each	17,038
Filed 2016-08-11 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	16,726
Filed 2016-08-11 Tx date 2016-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Robertson, Russel Clark 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-08-03	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$339,618 +14,458 vol $23.49 each	14,458
Filed 2016-08-11 Tx date 2016-07-22	$VRX Valeant Pharmaceuticals International, Inc.	Kavanagh, Sarah Baldwin 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	16,726
Filed 2016-08-11 Tx date 2016-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each
Filed 2016-08-11 Tx date 2016-06-14	$VRX Valeant Pharmaceuticals International, Inc.	Karabelas, Argeris 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-1,096 vol	16,726
Filed 2016-08-11 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	17,822
Filed 2016-08-11 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$408,114 +16,726 vol $24.40 each
Filed 2016-08-11 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	-26 vol	1,070
Filed 2016-08-11 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,096 vol	1,096
Filed 2016-08-11 Tx date 2016-03-08	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-08-11 Tx date 2016-08-08	$VRX Valeant Pharmaceuticals International, Inc.	Ackermann, Christina 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-07-21 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	79,735
Filed 2016-07-21 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	17,822
Filed 2016-07-21 Tx date 2016-06-13	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$97,600 +4,000 vol $24.40 each	4,000
Filed 2016-07-21 Tx date 2016-03-08	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-07-21 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Power, Robert Noel 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	26,221
Filed 2016-07-21 Tx date 2016-06-30	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$21,751 +1,080 vol $20.14 each	80,815
Filed 2016-07-21 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$408,114 +16,726 vol $24.40 each	17,822
Filed 2016-07-20 Tx date 2015-05-19	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-1,634 vol
Filed 2016-07-20 Tx date 2015-05-22	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,607 vol	1,607
Filed 2016-07-20 Tx date 2015-05-19	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-1,634 vol	0
Filed 2016-07-20 Tx date 2015-05-19	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-1,634 vol
Filed 2016-07-20 Tx date 2015-05-19	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,510 vol	1,510
Filed 2016-07-18 Tx date 2014-10-01	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Rights Deferred Share Units (DSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-07-18 Tx date 2014-10-01	$VRX Valeant Pharmaceuticals International, Inc.	Ubben, Jeffrey W. 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-07-06 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-07-06 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	-1,148 vol	16,726
Filed 2016-07-06 Tx date 2016-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	+1,114 vol	1,114
Filed 2016-06-22 Tx date 2016-06-17	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$374,996 +16,726 vol $22.42 each	17,874
Filed 2016-06-15 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-78,427,880.154 -2,114,586 vol $37.09 each	-2,114,586
Filed 2016-06-15 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-78,428,251.044 -2,114,596 vol $37.09 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$2,259,767 +63,122 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$90,629,812 +2,531,559 vol $35.80 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$90,629,812 +2,531,559 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$90,629,812 +2,531,559 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$101,595,924 +2,837,875 vol $35.80 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$101,595,924 +2,837,875 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$101,595,924 +2,837,875 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$2,259,767 +63,122 vol $35.80 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$2,259,767 +63,122 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$132,010,495 +3,687,444 vol $35.80 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$132,010,495 +3,687,444 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	$132,010,495 +3,687,444 vol $35.80 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-78,428,251.044 -2,114,596 vol $37.09 each	-2,114,596
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-78,427,880.154 -2,114,586 vol $37.09 each
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-78,427,880.154 -2,114,586 vol $37.09 each
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-100,000,585.737 -2,696,233 vol $37.09 each	-2,696,233
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-2,516,266.116 -67,844 vol $37.09 each	-67,844
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) 70 - Acquisition or disposition (writing) of third party derivative	$-157,306,947.993 -4,241,337 vol $37.09 each	-4,241,337
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	$-75,946.77 -2,531,559 vol $0.03 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	$-85,136.25 -2,837,875 vol $0.03 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	$-1,893.66 -63,122 vol $0.03 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	$-110,623.32 -3,687,444 vol $0.03 each	0
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$84,584 +21,146 vol $4.00 each	21,146
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	Listed Calls (including Options to Purchase ) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$107,848 +26,962 vol $4.00 each	26,962
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	Listed Calls (including Options to Purchase ) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$2,712 +678 vol $4.00 each	678
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	Listed Calls (including Options to Purchase ) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	Listed Calls (including Options to Purchase ) 70 - Acquisition or disposition (writing) of third party derivative	$169,656 +42,414 vol $4.00 each	42,414
Filed 2016-06-14 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	Listed Calls (including Options to Purchase ) 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-13 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-13 Tx date 2016-06-10	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$4,944,960 +202,000 vol $24.48 each	202,000
Filed 2016-06-13 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-06-13 Tx date 2016-06-09	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Options 50 - Grant of options	+682,652 vol	682,652
Filed 2016-05-16 Tx date 2016-05-12	$VRX Valeant Pharmaceuticals International, Inc.	Rosiello, Robert 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$2,118,426 +84,975 vol $24.93 each	105,750
Filed 2016-05-16 Tx date 2016-05-12	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$2,875,027 +115,324 vol $24.93 each	143,141
Filed 2016-05-16 Tx date 2016-05-12	$VRX Valeant Pharmaceuticals International, Inc.	Chai-Onn, Robert Roswell 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$1,513,176 +60,697 vol $24.93 each	62,375
Filed 2016-05-16 Tx date 2016-05-12	$VRX Valeant Pharmaceuticals International, Inc.	Whitaker, Anne 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$945,719 +37,935 vol $24.93 each	45,435
Filed 2016-05-11 Tx date 2015-10-25	$VRX Valeant Pharmaceuticals International, Inc.	Morfit, Garrison Mason 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,883 vol
Filed 2016-05-11 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$281,156 +1,148 vol $244.91 each	1,148
Filed 2016-05-11 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,148 vol
Filed 2016-05-11 Tx date 2015-10-25	$VRX Valeant Pharmaceuticals International, Inc.	Morfit, Garrison Mason 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$218,729 +1,883 vol $116.16 each	1,883
Filed 2016-05-10 Tx date 2015-10-25	$VRX Valeant Pharmaceuticals International, Inc.	Morfit, Garrison Mason 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-10 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,148 vol	1,148
Filed 2016-05-10 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-10 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		13,934,468
Filed 2016-05-10 Tx date 2015-08-19	$VRX Valeant Pharmaceuticals International, Inc.	Hale, David Robert 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-10 Tx date 2015-10-25	$VRX Valeant Pharmaceuticals International, Inc.	Morfit, Garrison Mason 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	+1,883 vol	1,883
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$12,190,432 +373,367 vol $32.65 each	373,367
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$30,476,032 +933,416 vol $32.65 each
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	$30,476,032 +933,416 vol $32.65 each	933,416
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Papa, Joseph 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 00 - Opening Balance-Initial SEDI Report
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Melas-Kyriazi, Theo 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$24,985 +950 vol $26.30 each	80,339
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$24,353 +926 vol $26.30 each	63,009
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Farmer, Ron 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$26,247 +998 vol $26.30 each	22,915
Filed 2016-05-04 Tx date 2016-05-02	$VRX Valeant Pharmaceuticals International, Inc.	Provencio, Norma Ann 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$31,244 +1,188 vol $26.30 each	57,196
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		5,964,831
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		148,741
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		6,697,420
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	-2,531,559 vol	-2,531,559
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	-2,837,875 vol	-2,837,875
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		8,780,130
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	-63,122 vol	-63,122
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 70 - Acquisition or disposition (writing) of third party derivative	-3,687,444 vol	-3,687,444
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Puts (including Private Options to Sell) Exercise US$60.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	+2,531,559 vol	2,531,559
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	+2,531,559 vol
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	+2,837,875 vol	2,837,875
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	+63,122 vol	63,122
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 70 - Acquisition or disposition (writing) of third party derivative	+3,687,444 vol	3,687,444
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$95.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	-2,531,559 vol	-2,531,559
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	-2,837,875 vol	-2,837,875
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square International, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	-63,122 vol	-63,122
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square II, L.P. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 70 - Acquisition or disposition (writing) of third party derivative	-3,687,444 vol	-3,687,444
Filed 2016-03-31 Tx date 2016-03-21	$VRX Valeant Pharmaceuticals International, Inc.	Ackman, William A. 4 - Director of Issuer Holder: Pershing Square Holdings, Ltd. (Control or Direction)	OTC Calls (including Private Options to Purchase) Exercise US$165.00 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-15 Tx date 2016-03-11	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$76,226 +1,096 vol $69.55 each	1,096
Filed 2016-03-15 Tx date 2016-03-11	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$76,226 +1,096 vol $69.55 each	1,096
Filed 2016-03-15 Tx date 2016-03-08	$VRX Valeant Pharmaceuticals International, Inc.	Ross Sr., Thomas 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-03-15 Tx date 2016-03-08	$VRX Valeant Pharmaceuticals International, Inc.	Eshelman, Fredric 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2016-02-22 Tx date 2016-02-18	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	$-558,027.90 -6,102 vol $91.45 each	1,506
Filed 2016-02-22 Tx date 2016-02-18	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Performance Share Units 57 - Exercise of rights	$-9,145,000 -100,000 vol $91.45 each	0
Filed 2016-02-22 Tx date 2016-02-18	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	$-4,741,316.70 -51,846 vol $91.45 each	335,278
Filed 2016-02-22 Tx date 2016-02-18	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$9,145,000 +100,000 vol $91.45 each	387,124
Filed 2016-02-22 Tx date 2016-02-18	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Common Shares 97 - Other	$-205,305.25 -2,245 vol $91.45 each	287,124
Filed 2016-02-22 Tx date 2016-02-18	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$558,027 +6,102 vol $91.45 each	289,369
Filed 2016-01-28 Tx date 2016-01-26	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-295,146.66 -3,317 vol $88.98 each	57,633
Filed 2016-01-28 Tx date 2016-01-26	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$857,055 +9,632 vol $88.98 each	60,950
Filed 2016-01-28 Tx date 2016-01-26	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	$-857,055.36 -9,632 vol $88.98 each	27,817
Filed 2016-01-28 Tx date 2014-05-20	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	$29,468,250 +225,000 vol $130.97 each	450,000
Filed 2016-01-28 Tx date 2014-05-20	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	$9,822,750 +75,000 vol $130.97 each
Filed 2016-01-28 Tx date 2014-01-09	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+225,000 vol	225,000
Filed 2016-01-28 Tx date 2014-01-09	$VRX Valeant Pharmaceuticals International, Inc.	Kellen, Ari 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 56 - Grant of rights	+75,000 vol
Filed 2016-01-05 Tx date 2015-12-31	$VRX Valeant Pharmaceuticals International, Inc.	Pearson, J. Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Performance Share Units 97 - Other	$-1,063,173.24 -14,412 vol $73.77 each	1,561,582
Filed 2016-01-04 Tx date 2015-12-31	$VRX Valeant Pharmaceuticals International, Inc.	Ingram, Robert A. 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$24,294 +239 vol $101.65 each	62,083
Filed 2016-01-04 Tx date 2015-07-01	$VRX Valeant Pharmaceuticals International, Inc.	Schiller, Howard 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$343,729 +1,506 vol $228.24 each	7,608
Filed 2016-01-04 Tx date 2015-12-31	$VRX Valeant Pharmaceuticals International, Inc.	Provencio, Norma Ann 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$34,967 +344 vol $101.65 each	56,008
Filed 2016-01-04 Tx date 2015-12-31	$VRX Valeant Pharmaceuticals International, Inc.	Melas-Kyriazi, Theo 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$24,904 +245 vol $101.65 each	79,389
Filed 2016-01-04 Tx date 2015-12-31	$VRX Valeant Pharmaceuticals International, Inc.	Farmer, Ron 4 - Director of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 56 - Grant of rights	$26,225 +258 vol $101.65 each	21,917
Filed 2015-11-24 Tx date 2015-11-20	$VRX Valeant Pharmaceuticals International, Inc.	JORN, DEBORA 5 - Senior Officer of Issuer Direct Ownership	Common Shares 97 - Other	$-124,670 -1,370 vol $91.00 each	6,928
Filed 2015-11-24 Tx date 2015-11-20	$VRX Valeant Pharmaceuticals International, Inc.	JORN, DEBORA 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 57 - Exercise of rights	$-240,331 -2,641 vol $91.00 each	27,884
Filed 2015-11-24 Tx date 2015-05-20	$VRX Valeant Pharmaceuticals International, Inc.	JORN, DEBORA 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report		30,525
Filed 2015-11-24 Tx date 2015-05-20	$VRX Valeant Pharmaceuticals International, Inc.	JORN, DEBORA 5 - Senior Officer of Issuer Direct Ownership	Rights Restricted Share Units (RSUs) 00 - Opening Balance-Initial SEDI Report
Filed 2015-11-24 Tx date 2015-11-20	$VRX Valeant Pharmaceuticals International, Inc.	JORN, DEBORA 5 - Senior Officer of Issuer Direct Ownership	Common Shares 57 - Exercise of rights	$240,331 +2,641 vol $91.00 each	8,298
Filed 2015-11-09 Tx date 2015-11-05	$VRX Valeant Pharmaceuticals International, Inc.	Pearson, J. Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-61,354,447.70 -800,345 vol $76.66 each	1,283,986
Filed 2015-11-09 Tx date 2015-11-05	$VRX Valeant Pharmaceuticals International, Inc.	Pearson, J. Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	-350,000 vol	933,986
Filed 2015-11-09 Tx date 2015-11-05	$VRX Valeant Pharmaceuticals International, Inc.	Pearson, J. Michael 4 - Director of Issuer, 5 - Senior Officer of Issuer Direct Ownership	Common Shares 10 - Acquisition or disposition in the public market	$-10,980,522.18 -147,054 vol $74.67 each	2,084,331
Filed 2015-11-04 Tx date 2015-10-25	$VRX Valeant Pharmaceuticals International, Inc.	Morfit, Garrison Mason 4 - Director of Issuer Holder: ValueAct Co-Invest Master Fund, L.P. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		1,059,793
Filed 2015-11-04 Tx date 2015-10-25	$VRX Valeant Pharmaceuticals International, Inc.	Morfit, Garrison Mason 4 - Director of Issuer Holder: ValueAct Capital Master Fund, L.P. (Control or Direction)	Common Shares 00 - Opening Balance-Initial SEDI Report		13,934,468
Filed 2015-10-27 Tx date 2015-10-26	$VRX Valeant Pharmaceuticals International, Inc.	Valeant Pharmaceuticals International, Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-200,000 vol	0
Filed 2015-10-27 Tx date 2015-10-21	$VRX Valeant Pharmaceuticals International, Inc.	Valeant Pharmaceuticals International, Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase